(19)
(11) EP 1 615 899 A1

(12)

(43) Date of publication:
18.01.2006 Bulletin 2006/03

(21) Application number: 04725121.0

(22) Date of filing: 01.04.2004
(51) International Patent Classification (IPC): 
C07D 263/32(1985.01)
C07D 405/06(1990.01)
C07C 61/04(1968.09)
C07D 401/04(1990.01)
C07D 411/12(1990.01)
C07D 249/06(1985.01)
C07D 213/66(1985.01)
C07C 59/125(1980.01)
C07D 413/12(1990.01)
C07D 307/79(1985.01)
C07D 413/14(1990.01)
C07D 417/14(1990.01)
(86) International application number:
PCT/IB2004/001159
(87) International publication number:
WO 2004/092145 (28.10.2004 Gazette 2004/44)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR
Designated Extension States:
AL HR LT LV MK

(30) Priority: 15.04.2003 US 463213 P

(71) Applicant: PFIZER INC.
New York, N.Y. 10017 (US)

(72) Inventors:
  • BAILEY, Simon, Pfizer Global R&D
    San Diego, CA 92121 (US)
  • HUMPHRIES, Paul Stuart, Pfizer Global R&D
    San Diego, CA 92121 (US)
  • SKALITZKY, Donald James, Pfizer Global R&D
    Ann Arbor, MI 48105 (US)
  • SU, Wei-Guo, Pfizer Global R&D
    San Diego, CA 92121 (US)
  • ZEHNDER, Luke Raymond, Pfizer Global R&D
    San Diego, CA 92121 (US)

(74) Representative: Motion, Keith Robert 
Pfizer Limited, European Pharma Patent Department, Ramsgate Road
Sandwich, Kent CT13 9NJ
Sandwich, Kent CT13 9NJ (GB)

   


(54) ALPHA-SUBSTITUTED CARBOXYLIC ACIDS AS PPAR MODULATORS